Latest & greatest articles for colon cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on colon cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on colon cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for colon cancer screening

81. Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk Population: A Randomized Trial. Full Text available with Trip Pro

Genetic and Environmental Risk Assessment and Colorectal Cancer Screening in an Average-Risk Population: A Randomized Trial. New methods are needed to improve health behaviors, such as adherence to colorectal cancer (CRC) screening. Personalized genetic information to guide medical decisions is increasingly available. Whether such information motivates behavioral change is unknown.To determine whether individualized genetic and environmental risk assessment (GERA) of CRC susceptibility improves (...) adherence to screening in average-risk persons.2-group, randomized, controlled trial. (ClinicalTrials.gov: NCT0087360).4 medical school-affiliated primary care practices.783 participants at average risk for CRC who were not adherent to screening at study entry.Participants were randomly assigned to usual care or GERA, which evaluated methylenetetrahydrofolate reductase polymorphisms and serum folate levels. On the basis of prespecified combinations of polymorphisms and serum folate levels, GERA

2014 Annals of Internal Medicine Controlled trial quality: predicted high

82. Population-based colorectal cancer screening: guidelines

Population-based colorectal cancer screening: guidelines Population-based colorectal cancer screening: guidelines Population-based colorectal cancer screening: guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Population-based colorectal cancer screening: guidelines. Ottawa: Canadian Agency for Drugs and Technologies (...) in Health (CADTH). Rapid Response - Reference List. 2014 Authors' conclusions Three evidence-based guidelines were identified associated with population-based colorectal cancer screening guidelines for the average risk population. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Colorectal Neoplasmss; Mass Screening Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address

2014 Health Technology Assessment (HTA) Database.

83. Should colorectal cancer screening be considered in elderly persons without previous screening?: a cost-effectiveness analysis. Full Text available with Trip Pro

Should colorectal cancer screening be considered in elderly persons without previous screening?: a cost-effectiveness analysis. The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening.To determine at what ages CRC screening should be considered in unscreened elderly persons and to determine which (...) at age 78 years, and FIT at ages 79 and 80 years).Results were most sensitive to assuming a lower willingness to pay per quality-adjusted life-year gained.Only persons at average risk for CRC were considered.In unscreened elderly persons CRC screening should be considered well beyond age 75 years. A colonoscopy is indicated at most ages.National Cancer Institute.

2014 Annals of Internal Medicine

84. From the bench to public health: population-level implementation intentions in colorectal cancer screening (Abstract)

From the bench to public health: population-level implementation intentions in colorectal cancer screening Early detection of colorectal cancer (CRC) using fecal occult blood test (FOBT) reduces mortality, yet screening adherence remains low.Enhancing FOBT adherence in a field experiment, using Implementation Intentions (II) technique.Participants were randomly assigned to a standard care group or to II experimental group.A test kit was mailed to 29,833 HMO-insured members in two waves in 2011 (...) screening, even in a mailed form rather than a face-to-face experimental situation. Mailed II is an inexpensive and effective method, applicable for public health.© 2014 American Journal of Preventive Medicine Published by American Journal of Preventive Medicine All rights reserved.

2014 EvidenceUpdates Controlled trial quality: uncertain

85. Population-Based Colorectal Cancer Screening

and surveillance. Gastrointest Endosc. 2006 Apr;63(4):546-57. PubMed: PM16564851 19. Flook N. Colorectal cancer. Summary of Canadian screening guidelines. Can Fam Physician. 2004 Apr;50:592-3. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2214593 PubMed: PM15116806 20. Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol. 2004 Feb;18(2):93 (...) from the American College of Physicians. Ann Intern Med. 2012 Mar 6;156(5):378-86. PubMed: PM22393133 14. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v70-v77. PubMed: PM20555107 15. Lieberman D. Colorectal cancer screening: practice guidelines. Dig Dis. 2012;30 Suppl 2:34-8. PubMed: PM23207930 16. Telford JJ

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

86. Stool DNA and Colorectal-Cancer Screening. Full Text available with Trip Pro

, Seattle (J.A.D.). Dominitz Jason A JA eng Editorial Comment 2014 03 19 United States N Engl J Med 0255562 0028-4793 0 DNA, Neoplasm AIM IM N Engl J Med. 2014 Apr 3;370(14):1287-97 24645800 Colorectal Neoplasms diagnosis DNA Mutational Analysis DNA, Neoplasm analysis Early Detection of Cancer methods Feces chemistry Female Humans Male Mass Screening methods Precancerous Conditions diagnosis 2014 3 21 6 0 2014 3 22 6 0 2014 4 16 6 0 ppublish 24645801 10.1056/NEJMe1400092 (...) Stool DNA and Colorectal-Cancer Screening. 24645801 2014 04 15 2018 12 02 1533-4406 370 14 2014 Apr 03 The New England journal of medicine N. Engl. J. Med. Stool DNA and colorectal-cancer screening. 1350-1 10.1056/NEJMe1400092 Robertson Douglas J DJ From the White River Junction Veterans Affairs (VA) Medical Center, White River Junction, VT, and Geisel School of Medicine at Dartmouth, Hanover, NH (D.J.R.); and the VA Puget Sound Health Care System, University of Washington School of Medicine

2014 NEJM

87. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. Full Text available with Trip Pro

Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. To examine whether the age based quality measure for screening for colorectal cancer is associated with overuse of screening in patients aged 70-75 in poor health and underuse in those aged over age 75 in good health.Retrospective cohort study utilizing electronic data from the Veterans Affairs (VA) Health Care System, the largest integrated healthcare system in the United States.VA (...) Health Care System.Veterans aged ≥ 50 due for repeat average risk colorectal cancer screening at a primary care visit in fiscal year 2010.Completion of colonoscopy, sigmoidoscopy, or fecal occult blood testing within 24 months of the 2010 visit.399,067 veterans met inclusion/exclusion criteria (mean age 67, 97% men). Of these, 38% had electronically documented screening within 24 months. In multivariable log binomial regression adjusted for Charlson comorbidity index, sex, and number of primary care

2014 BMJ

88. Assessment of the benefit of screening in persons aged under 55 years with a risk of familial bowel cancer

Assessment of the benefit of screening in persons aged under 55 years with a risk of familial bowel cancer Bewertung des nutzens einer früherkennungs-untersuchung für personen unter 55 jahren mit familiärem darmkrebsrisiko [Assessment of the benefit of screening in persons aged under 55 years with a risk of familial bowel cancer] Bewertung des nutzens einer früherkennungs-untersuchung für personen unter 55 jahren mit familiärem darmkrebsrisiko [Assessment of the benefit of screening in persons (...) aged under 55 years with a risk of familial bowel cancer] IQWiG Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation IQWiG. Bewertung des nutzens einer früherkennungs-untersuchung für personen unter 55 jahren mit familiärem darmkrebsrisiko. [Assessment of the benefit of screening in persons aged under 55 years with a risk of familial bowel cancer

2014 Health Technology Assessment (HTA) Database.

89. The fecal occult blood test (FOBT) to screen for colorectal cancer

relatives who developed cancer before 50 years old, or with multiple affected first-degree relatives. This test does not apply to individuals at greater than average risk for colorectal cancer who should follow guidelines specific to their personal and family histories. Risk factors that put an individual at greater than average risk for colorectal cancer are : inflammatory bowel disease and certain inherited syndromes (Lynch syndrome/hereditary nonpolyposis colorectal cancer (HNPCC), Familial polyposis (...) The fecal occult blood test (FOBT) to screen for colorectal cancer Boîte à décision | Pdf boxe Back to the Decision boxes × My account Creating an account and signing in will allow you to keep your Decision box results and view them later. I do not have an account Provide some personal information and create a user account allowing to save your Decision box results and view them later. You can also: I already have an account Please enter your email address and password to access your profile

2014 Cancer Council Australia

90. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. Full Text available with Trip Pro

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. Colorectal cancer is a major health burden. Screening is recommended in many countries.To estimate the effectiveness of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality in a population-based trial.Randomized clinical trial of 100,210 individuals aged 50 to 64 years, identified from the population of Oslo city and Telemark County, Norway. Screening (...) was performed in 1999-2000 (55-64-year age group) and in 2001 (50-54-year age group), with follow-up ending December 31, 2011. Of those selected, 1415 were excluded due to prior colorectal cancer, emigration, or death, and 3 could not be traced in the population registry.Participants randomized to the screening group were invited to undergo screening. Within the screening group, participants were randomized 1:1 to receive once-only flexible sigmoidoscopy or combination of once-only flexible sigmoidoscopy

2014 JAMA Controlled trial quality: predicted high

91. [Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test]

[Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test] Eficacia, seguridad y eficiencia de la colonografía por tomografía computerizada frente a la colonoscopia como prueba de cribado del cáncer colorrectal [Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test] Eficacia, seguridad y eficiencia de la colonografía por tomografía computerizada frente a la (...) colonoscopia como prueba de cribado del cáncer colorrectal [Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test] Martín-López JE, Márquez-Peláez S, Adam-Blanco D, Navarro-Caballero JA, Rodríguez-López R, Beltrán-Calvo C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Martín-López JE

2014 Health Technology Assessment (HTA) Database.

92. The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. Full Text available with Trip Pro

colorectal cancer screening programme, offering considerable potential for risk reduction of disease in older adults.Current Controlled Trials ISRCTN53033856. (...) The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. To evaluate the impact of a diet and physical activity intervention (BeWEL) on weight change in people with a body mass index >25 weight (kg)/height (m)(2) at increased risk of colorectal cancer and other obesity related comorbidities.Multicentre, parallel group, randomised controlled trial.Four Scottish National Health Service

2014 BMJ Controlled trial quality: predicted high

93. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects (Abstract)

for colorectal neoplasia, defined as adenoma, advanced neoplasia, colorectal cancer or any combination thereof using binary regression analysis. The ORs for significant risk factors were used to develop a scoring system ranging from 0 to 6: 0-2 'average risk' (AR) and 3-6 'high risk' (HR). The other 3220 screening participants prospectively enrolled between 2008 and 2012 for screening colonoscopy formed an independent validation cohort. The performance of the scoring system for predicting colorectal (...) A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects We aim to develop and validate a clinical scoring system to predict the risks of colorectal neoplasia to better inform screening participants and facilitate their screening test choice.We recruited 5220 Chinese asymptomatic screening participants who underwent colonoscopy in Hong Kong during 2008-2012. From random sampling of 2000 participants, independent risk factors were evaluated

2013 EvidenceUpdates

94. Effects of facilitated team meetings and learning collaboratives on colorectal cancer screening rates in primary care practices: a cluster randomized trial Full Text available with Trip Pro

Effects of facilitated team meetings and learning collaboratives on colorectal cancer screening rates in primary care practices: a cluster randomized trial The purpose of this study was to evaluate a primary care practice-based quality improvement (QI) intervention aimed at improving colorectal cancer screening rates.The Supporting Colorectal Cancer Outcomes through Participatory Enhancements (SCOPE) study was a cluster randomized trial of New Jersey primary care practices. On-site facilitation (...) and learning collaboratives were used to engage multiple stakeholders throughout the change process to identify and implement strategies to enhance colorectal cancer screening. Practices were analyzed using quantitative (medical records, surveys) and qualitative data (observations, interviews, and audio recordings) at baseline and a 12-month follow-up.Comparing intervention and control arms of the 23 participating practices did not yield statistically significant improvements in patients' colorectal cancer

2013 EvidenceUpdates Controlled trial quality: uncertain

95. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Full Text available with Trip Pro

Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Chinese translationBlack persons are more likely than white persons to be diagnosed with colorectal cancer and to die from it. The extent to which genetic or biological factors versus disparities in screening rates explain this variance remains controversial.To define the prevalence and location of presymptomatic advanced colorectal neoplasia (ACN) among white (...) [CI, 0.73 to 2.40]). Black patients with ACN had a higher percentage of proximal disease (52% vs. 39%) after adjustment for age and sex (P = 0.055).Single-institution study with inadequate statistical power for subgroup analyses and recall bias.Black men are less likely than white men to have ACN at screening colonoscopy in a safety-net health care setting. Disparities in access to screening and differential exposure to modifiable risk factors rather than genetic or biological factors may

2013 Annals of Internal Medicine

96. Colorectal Screening for Cancer Prevention in Asymptomatic Patients

Colorectal Screening for Cancer Prevention in Asymptomatic Patients BC Guidelines - Province of British Columbia theme_3_collection theme_3_frontend theme_3_collection theme_3_frontend Birth, Adoption, Death, Marriage & Divorce theme_1_collection theme_1_frontend theme_1_collection theme_1_frontend British Columbians & Our Governments theme_data_collection data_frontend theme_data_collection data_frontend Data theme_5_collection theme_5_frontend theme_5_collection theme_5_frontend Driving (...) , Recreation, Arts & Culture theme_8_collection theme_8_frontend theme_8_collection theme_8_frontend Taxes & Tax Credits theme_14_collection theme_14_frontend theme_14_collection theme_14_frontend Tourism & Immigration Search default_collection default_frontend Section Navigation BC Guidelines BC Guidelines are clinical practice guidelines and protocols that provide recommendations to B.C. practitioners on delivering high quality, appropriate care to patients with specific clinical conditions or diseases

2013 Clinical Practice Guidelines and Protocols in British Columbia

97. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Full Text available with Trip Pro

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. The effectiveness of screening colonoscopy in average-risk adults is uncertain, particularly for right colon cancer.To examine the association between screening colonoscopy and risk for incident late-stage colorectal cancer (CRC).Nested case-control study.Four U.S. health plans.1039 average-risk adults enrolled for at least 5 years in one of the health plans (...) conditional logistic regression that accounted for health history, socioeconomic status, and other screening exposures.In analyses restricted to 471 eligible case patients and their 509 matched control patients, 13 case patients (2.8%) and 46 control patients (9.0%) had undergone screening colonoscopy, which corresponded to an adjusted odds ratio (AOR) of 0.29 (95% CI, 0.15 to 0.58) for any late-stage CRC, 0.36 (CI, 0.16 to 0.80) for right colon cancer, and 0.26 (CI, 0.06 to 1.11; P = 0.069) for left

2013 Annals of Internal Medicine

98. Screening for colorectal cancer part 1: screening-tests and program design

Screening for colorectal cancer part 1: screening-tests and program design Screening for colorectal cancer part 1: screening-tests and program design Screening for colorectal cancer part 1: screening-tests and program design Patera N, Schumacher I Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Patera N, Schumacher I. Screening (...) for colorectal cancer part 1: screening-tests and program design. Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). HTA project report No.: 41a. 2012 Authors' conclusions - program design (quality) and participation rate matter - choice of screening-test is of secondary importance - CRC-screening is not simply about choosing the right initial test for screening - effective CRC-screening is about establishing a quality assured screening-program integrating diagnosis, treatment

2013 Health Technology Assessment (HTA) Database.

99. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial Full Text available with Trip Pro

Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial Shared decision making (SDM) is a widely recommended yet unproven strategy for increasing colorectal cancer (CRC) screening uptake. Previous trials of decision aids to increase SDM and CRC screening uptake have yielded mixed results.To assess the impact of decision aid-assisted SDM on CRC screening uptake.RCT.The study was conducted at an urban, academic safety-net hospital and community health center (...) between 2005 and 2010. Participants were asymptomatic, average-risk patients aged 50-75 years due for CRC screening.Study participants (n=825) were randomized to one of two intervention arms (decision aid plus personalized risk assessment or decision aid alone) or control arm. The interventions took place just prior to a routine office visit with their primary care providers.The primary outcome was completion of a CRC screening test within 12 months of the study visit. Logistic regression was used

2013 EvidenceUpdates Controlled trial quality: predicted high

100. Population Screening Act: national population screening programme for bowel cancer

. Population Screening Act: national population screening programme for bowel cancer. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2013/19. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Colorectal Neoplasms; Early Detection of Cancer; Humans; Mass Screening; Netherlands Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag (...) Population Screening Act: national population screening programme for bowel cancer Population Screening Act: national population screening programme for bowel cancer Population Screening Act: national population screening programme for bowel cancer Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands

2013 Health Technology Assessment (HTA) Database.